Um Manual Programático
A publicação deste documento foi possível graças ao apoio da Comissão Europeia (auxílio Sante 2007141-838). O conteúdo deste documento é de responsabilidade única de A Union e não reflete a opinião da Comissão Europeia.
El documento provee algunas consideraciones sobre su utilidad e indicaciones definidas por el MSPS en nuestro país. Adicionalmente, incluye anexos y material fotográfico de las experiencias de campo, los cuales permiten complementar los
contenidos que se desarrollan en la presente publicación
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...tivities has been largely guided by small and large pharmaceutical companies according to a variety of parameters, such as perceived/unmet medical need, pressure of investors, market size, scientific discovery potential, and availability of specific technologies. Previous PPLs, issued by the Centers for Disease Control and Prevention.
more
Última modificação: 28.05.2020; Data da publicação: 04.07.2017. O objetivo desta cartilha é apresentar o tema da tuberculose oferecendo subsídios para o desenvolvimento do trabalho do ACS. Seu formato foi pensado para facilitar a consulta e o manuseio, principalmente auxiliando o esclarecimen...to de dúvidas durante a visita domiciliar de forma objetiva. Visa também destacar o olhar para a tuberculose, contribuindo com o controle da doença e o cuidado das pessoas no território de atuação.
more
Основная цель этого Руководства состоит в том, чтобы очертить рамки методов, используемых для оценки распространенности ВИЧ-инфекции среди больных туберкулезом и... способствовать осуществле-нию эпиднадзора за ВИЧ-инфекцией.
more
Emerging Infectious Diseases; Vol. 21, No. 11, November 2015
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...antibiotic era - rheumatic fever, syphilis, cellulitis and bacterial pneumonia - became treatable, and over the next 20 years most of the classes of antibiotics that find clinical use today were discovered and changed medicine in a profound way. The availability of antibiotics enabled revolutionary medical interventions such as cancer chemotherapy, organ transplants and essentially all major invasive surgeries from joint replacements to coronary bypass. Antibiotics, though, are unique among drugs in that their use precipitates their obsolescence. Paradoxically, these cures select for organisms that can evade them, fueling an arms race between microbes, clinicians and drug discoverers.
Wright BMC Biology 2010, 8:123 http://www.biomedcentral.com/1741-7007/8/12
more
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
BMC International Health and Human Rights 2012, 12 :12
http://www.biomedcentral.com/1472-698X/12/12
A manual for programme managers.
La publicación evalúa en forma cuantitativa y cualitativa el costo socioeconómico de la tuberculosis en el Perú con la finalidad de mejorar la comprensión real de gasto social y costo que representa para las personas, familias y Estado peruano. Asimismo, desarrolla bajo el marco del Objetivo 4 ...del programa “Haciendo la diferencia: Consolidando una respuesta integral contra la tuberculosis en el Perú.
more
The review’s objectives are to review progress in TB control with emphasis on DOTS strategy implementation, summarize the experience, lessons learnt and methods of work and to make recommendations for international donors, technical agencies and the Ministry of Health.
A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov...er the four rounds. However, the proportion of laboratories reporting false–positive cases remains high and indicates a problem of specificity probably due to contamination. The proportion of laboratories reporting both false–positive and false–negative results raises the issue of the quality of the data reported by WHO in Africa as well as the results of the studies carried out in these different laboratories in various countries.
more
(Stand: 14. September 2015). Medizinisches Personal, welches Asylsuchende (sowie Asylbewerber, Flüchtlinge) betreut, sollte auf einige dieser für Deutschland ungewöhnlichen Erkrankungen vorbereitet sein. Das RKI hat im Epidemiologischen Bulletin 38/2015 eine tabellerarische Übersicht veröffentl...icht.
more